Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Cash on Hand 2010-2025 | SIGA

Siga Technologies cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Siga Technologies Annual Cash on Hand
(Millions of US $)
2024 $155
2023 $150
2022 $99
2021 $103
2020 $118
2019 $161
2018 $112
2017 $31
2016 $39
2015 $113
2014 $104
2013 $91
2012 $32
2011 $49
2010 $21
2009 $19
Siga Technologies Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $162
2024-12-31 $155
2024-09-30 $99
2024-06-30 $107
2024-03-31 $144
2023-12-31 $150
2023-09-30 $71
2023-06-30 $76
2023-03-31 $116
2022-12-31 $99
2022-09-30 $110
2022-06-30 $115
2022-03-31 $153
2021-12-31 $103
2021-09-30 $93
2021-06-30 $98
2021-03-31 $107
2020-12-31 $118
2020-09-30 $79
2020-06-30 $53
2020-03-31 $77
2019-12-31 $161
2019-09-30 $89
2019-06-30 $112
2019-03-31 $114
2018-12-31 $112
2018-09-30 $108
2018-06-30 $22
2018-03-31 $25
2017-12-31 $31
2017-09-30 $36
2017-06-30 $41
2017-03-31 $40
2016-12-31 $39
2016-09-30 $20
2016-06-30 $78
2016-03-31 $104
2015-12-31 $113
2015-09-30 $129
2015-06-30 $116
2015-03-31 $96
2014-12-31 $104
2014-09-30 $105
2014-06-30 $99
2014-03-31 $107
2013-12-31 $91
2013-09-30 $105
2013-06-30 $33
2013-03-31 $25
2012-12-31 $32
2012-09-30 $23
2012-06-30 $35
2012-03-31 $43
2011-12-31 $49
2011-09-30 $12
2011-06-30 $15
2011-03-31 $19
2010-12-31 $21
2010-09-30 $19
2010-06-30 $15
2010-03-31 $17
2009-12-31 $19
2009-09-30 $1
2009-06-30 $2
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.444B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.949B 32.62
Zoetis (ZTS) United States $74.394B 27.76
Takeda Pharmaceutical (TAK) Japan $48.493B 9.65
Daiichi Sankyo, - (DSNKY) Japan $47.908B 24.55
BeOne Medicines - (ONC) Cayman Islands $28.843B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.294B 0.00
Merck (MKKGY) Germany $17.183B 12.59
Summit Therapeutics (SMMT) United States $16.398B 0.00
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $12.691B 11.23
Neurocrine Biosciences (NBIX) United States $12.348B 42.29
IPSEN (IPSEY) France $10.086B 0.00
Orion OYJ (ORINY) Finland $10.083B 27.27
Corcept Therapeutics (CORT) United States $7.664B 62.30
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.268B 0.00
Grifols, S.A (GRFS) Spain $6.202B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.863B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $4.021B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.209B 11.24
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.097B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.452B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.448B 13.24
BioCryst Pharmaceuticals (BCRX) United States $2.304B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.215B 0.00
Indivior (INDV) United States $1.888B 8.01
Dyne Therapeutics (DYN) United States $1.680B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.619B 0.00
Evotec AG (EVO) Germany $1.467B 0.00
ARS Pharmaceuticals (SPRY) United States $1.443B 0.00
Ocular Therapeutix (OCUL) United States $1.419B 0.00
Guardian Pharmacy Services (GRDN) United States $1.306B 0.00
Harrow (HROW) United States $1.143B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Enliven Therapeutics (ELVN) United States $1.065B 0.00
Akebia Therapeutics (AKBA) United States $1.030B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.976B 5.26
Ardelyx (ARDX) United States $0.895B 0.00
Cronos Group (CRON) Canada $0.752B 0.00
Elite Pharmaceuticals (ELTP) United States $0.748B 0.00
Xeris Biopharma Holdings (XERS) United States $0.712B 0.00
KalVista Pharmaceuticals (KALV) United States $0.706B 0.00
Xencor (XNCR) United States $0.693B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
AleAnna (ANNA) United States $0.584B 0.00
Liminatus Pharma (LIMN) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.49
Regulus Therapeutics (RGLS) United States $0.575B 0.00
Verve Therapeutics (VERV) United States $0.569B 0.00
Bioventus (BVS) United States $0.564B 14.29
Altimmune (ALT) United States $0.547B 0.00
Theravance Biopharma (TBPH) United States $0.537B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.513B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Oruka Therapeutics (ORKA) United States $0.494B 0.00
Tourmaline Bio (TRML) United States $0.488B 0.00
Organogenesis (ORGO) United States $0.440B 0.00
Savara (SVRA) United States $0.403B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 10.41
Aquestive Therapeutics (AQST) United States $0.356B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
ProKidney (PROK) United States $0.293B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 24.24
Esperion Therapeutics (ESPR) United States $0.242B 0.00
MediWound (MDWD) Israel $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.229B 0.00
4D Molecular Therapeutics (FDMT) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
OmniAb (OABI) United States $0.188B 0.00
Larimar Therapeutics (LRMR) United States $0.186B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.162B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Lyell Immunopharma (LYEL) United States $0.160B 0.00
Avita Medical (RCEL) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Nektar Therapeutics (NKTR) United States $0.141B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.129B 0.00
Achieve Life Sciences (ACHV) Canada $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Fractyl Health (GUTS) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Inotiv (NOTV) United States $0.098B 0.00
OptiNose (OPTN) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Champions Oncology (CSBR) United States $0.089B 14.68
Nutriband (NTRB) United States $0.086B 0.00
Galectin Therapeutics (GALT) United States $0.085B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.082B 61.22
Dominari Holdings (DOMH) United States $0.080B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Rafael Holdings (RFL) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Klotho Neurosciences (KLTO) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
NRx Pharmaceuticals (NRXP) United States $0.063B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
Century Therapeutics (IPSC) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Carisma Therapeutics (CARM) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
China SXT Pharmaceuticals (SXTC) China $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
Jupiter Neurosciences (JUNS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Relmada Therapeutics (RLMD) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Vivos Therapeutics (VVOS) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00